PlainRecalls
FDA Drug Critical Class I Terminated

Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.

Reported: July 15, 2015 Initiated: April 23, 2015 #D-1216-2015

Product Description

Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.

Reason for Recall

Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.

Details

Recalling Firm
Hospira Inc.
Units Affected
150,950 Vials
Distribution
U.S. Nationwide including Guam.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.. Recalled by Hospira Inc.. Units affected: 150,950 Vials.
Why was this product recalled?
Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 15, 2015. Severity: Critical. Recall number: D-1216-2015.